In this article
A useful Mochi Health review should explain what happens after the initial advertisement: who qualifies, how ongoing care is arranged, and which practical questions still need an answer. This guide brings the relevant company policies together with medical context.
We checked the accessible primary sources on September 23, 2026 and identify dated or unavailable documents where relevant. Provider statements are attributed, unresolved details remain explicit, and none of these answers is a personal prescribing decision. Use the linked original policy when confirming the terms for your own plan.
Mochi’s eligibility article describes BMI greater than 30, or greater than 27 with a weight-related condition, and also identifies prior weight-loss medication or weight regain after bariatric surgery as reasons for assessment. Its FAQ distinguishes joining the service from qualifying for a prescription.
What to know first
- Mochi’s eligibility article describes BMI greater than 30, or greater than 27 with a weight-related condition, and also identifies prior weight-loss medication or weight regain after bariatric surgery as reasons for assessment. Its FAQ distinguishes joining the service from qualifying for a prescription.
- We did not verify a public Mochi guarantee that a pause automatically stops both membership and medication charges. Its FAQ describes separate membership and medication arrangements, so a request to delay a prescription should not be assumed to suspend membership.
- Yes, Mochi’s FAQ describes a later program phase involving repeat labs and a discussion of next steps for maintenance. It does not promise one universal maintenance drug, dose, appointment interval, or reduced price.
What BMI and health criteria apply to Mochi Health?
Mochi’s eligibility article describes BMI greater than 30, or greater than 27 with a weight-related condition, and also identifies prior weight-loss medication or weight regain after bariatric surgery as reasons for assessment. Its FAQ distinguishes joining the service from qualifying for a prescription.
The article uses greater-than wording, while general NIDDK guidance uses 30 or above and 27 or above with a condition. Ask the clinician about a boundary value or continuing-care history; a calculator is not a final prescribing decision.
Can I pause Mochi Health without cancelling?
We did not verify a public Mochi guarantee that a pause automatically stops both membership and medication charges. Its FAQ describes separate membership and medication arrangements, so a request to delay a prescription should not be assumed to suspend membership.
Ask patient support to identify the exact control available on your plan, the next charge, any retained balance, and the restart conditions. Obtain confirmation before the renewal deadline and discuss any interruption with the clinician.
Does Mochi provide maintenance after goal weight?
Yes, Mochi’s FAQ describes a later program phase involving repeat labs and a discussion of next steps for maintenance. It does not promise one universal maintenance drug, dose, appointment interval, or reduced price.
Ask your clinician what maintenance means for your health history and ask billing what the proposed plan costs. The published program phase establishes a follow-up discussion, not a guaranteed outcome or a standard schedule everyone should copy.
Can I switch to Mochi with an existing prescription?
Mochi’s FAQ says it can continue a previous dose when documentation of the prior medication is supplied. Treat this as the company’s stated pathway: the receiving clinician still needs to evaluate the actual prescription, medical history, and any treatment gap.
Bring the prescription, dispensing label, last treatment date, and recent clinician notes. Ask what documentation is accepted and whether a new prescription and pharmacy fill are required. Do not assume syringe units transfer between concentrations.
Can someone under 18 join Mochi?
Mochi says it has a separate Pediatrics program for people under 18 and directs families to an eligibility form. This does not establish that every child qualifies for medication or that adult treatment criteria apply.
Use the dedicated pediatric intake with a parent or guardian where required. Ask the pediatric clinician about age, growth, relevant conditions, the exact approved or compounded product, and follow-up. Adult BMI thresholds alone do not answer pediatric eligibility.
Can I change my Mochi clinician when visits are unavailable?
Yes. Mochi’s FAQ says patients whose provider lacks follow-up availability can switch to a provider with more availability through the patient portal or by contacting the team.
Ask about the earliest suitable appointment and whether your records and refill tasks will be available to the new clinician. The option to change providers is not a promise of a same-day appointment or automatic prescription approval.
Does Mochi help with prior authorization?
Mochi says its team assists with prior authorizations and letters of medical necessity, including providing documentation to insurers. It also says coverage depends on the insurer, plan, and employer.
Provide current insurance details and ask who tracks the request, whether the medication is on the formulary, and what happens after a denial. Paperwork support does not guarantee approval, a fixed insurer response deadline, or coverage for a compounded product.
What are Mochi customer support hours?
Mochi’s FAQ publishes 24/7 customer support and the number (619) 648-1247. It also describes provider messaging. This supports an administrative availability claim, not a guaranteed immediate clinician response.
For appointment trouble, use the portal or support route. For clinical concerns, contact the prescribing team. Ask for the expected response time and appropriate escalation when a refill or follow-up visit is time-sensitive.
Does Mochi cost more at higher doses?
Yes. Mochi’s August 2026 pricing article lists compounded semaglutide at $60–$99 and compounded tirzepatide at $90–$199 per monthly vial, depending on prescribed dose. Membership is separate.
The lowest advertised price is therefore not the medication price at every dose. Review the quote for your actual prescription and membership term; do not choose or change a dose because of a price table.
How does Mochi pricing change after month one?
Mochi’s pricing article describes a $39 first-month membership offer. Its FAQ lists the standard monthly membership at $79, with other prepaid terms available; medication costs are additional and dose-dependent.
At the lowest listed doses, the introductory totals are $99 for semaglutide and $129 for tirzepatide. Continuing on a $79 monthly membership would make those same starting-dose totals $139 and $169, before any changed offer or prescription. Confirm your chosen term at checkout.
Read the complete answer to each question
Each question below has its own article, with a direct answer, practical context, and the documents behind it.
- What BMI and health criteria apply to Mochi Health?
- Can I pause Mochi Health without cancelling?
- Does Mochi Health provide maintenance treatment after reaching a goal?
- Can I switch to Mochi Health while continuing an existing prescription?
- Can someone under 18 join Mochi Health?
- Can I change my Mochi Health clinician when appointments are unavailable?
- Does Mochi Health help with prior authorization and medical-necessity paperwork?
- What are Mochi Health customer support hours, including weekends?
- Does the Mochi Health price change at a higher prescribed dose?
- How does Mochi Health pricing change after the first membership month?
Sources & research notes
Checked September 23, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- How to Qualify for Weight Loss Medications | Mochi HealthProvider-published information · Checked September 23, 2026
- FAQ | Mochi HealthProvider-published information · Checked September 23, 2026
- Prescription Medications to Treat Overweight & Obesity - NIDDKMedical reference · Checked September 23, 2026
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDARegulatory / public agency · Checked September 23, 2026
- New Per-Dose Pricing: What Changed | Mochi HealthProvider-published information · Checked September 23, 2026
Read our methodology · Commercial disclosure · Request a correction